CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium

Ruth C. Travis, Fredrick Schumacher, Joel N. Hirschhorn, Peter Kraft, Naomi E. Allen, Demetrius Albanes, Goran Berglund, Sonja I. Berndt, Heiner Boeing, H. Bas Bueno-de-Mesquita, Eugenia E. Calle, Stephen Chanock, Alison M. Dunning, Richard Hayes, Heather Spencer Feigelson, J. Michael Gaziano, Edward Giovannucci, Christopher A. Haiman, Brian E. Henderson, Rudolf KaaksLaurence N. Kolonel, Ma Jing, Laudina Rodriguez, Elio Riboli, Meir Stampfer, Daniel O. Stram, Michael J. Thun, Anne Tjønneland, Dimitrios Trichopoulos, Paolo Vineis, Jarmo Virtamo, Loïc Le Marchand, David J. Hunter

Research output: Contribution to journalArticle

Abstract

Sex hormones, particularly the androgens, are important for the growth of the prostate gland and have been implicated in prostate cancer carcinogenesis, yet the determinants of endogenous steroid hormone levels remain poorly understood. Twin studies suggest a heritable component for circulating concentrations of sex hormones, although epidemiologic evidence linking steroid hormone gene variants to prostate cancer is limited. Here we report on findings from a comprehensive study of genetic variation at the CYP19A1 locus in relation to prostate cancer risk and to circulating steroid hormone concentrations in men by the Breast and Prostate Cancer Cohort Consortium (BPC3), a large collaborative prospective study. The BPC3 systematically characterized variation in CYP19A1 by targeted resequencing and dense genotyping; selected haplotypetagging single nucleotide polymorphisms (htSNP) that efficiently predict common variants in U.S. and European whites, Latinos, Japanese Americans, and Native Hawaiians; and genotyped these htSNPs in 8,166 prostate cancer cases and 9,079 study-, age-, and ethnicity-matched controls. CYP19A1 htSNPs, two common missense variants and common haplotypes were not significantly associated with risk of prostate cancer. However, several htSNPs in linkage disequilibrium blocks 3 and 4 were significantly associated with a 5% to 10% difference in estradiol concentrations in men [association per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 1 × 10-5], and with inverse, although less marked changes, in free testosterone concentrations. These results suggest that although germline variation in CYP19A1 characterized by the htSNPs produces measurable differences in sex hormone concentrations in men, they do not substantially influence risk of prostate cancer.

Original languageEnglish (US)
Pages (from-to)2734-2744
Number of pages11
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number10
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Gonadal Steroid Hormones
Prostatic Neoplasms
Breast Neoplasms
Steroids
Hormones
Haplotypes
Single Nucleotide Polymorphism
Oceanic Ancestry Group
Twin Studies
Asian Americans
Linkage Disequilibrium
Hispanic Americans
Androgens
Testosterone
Prostate
Estradiol
Carcinogenesis
Prospective Studies
Growth
Genes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium. / Travis, Ruth C.; Schumacher, Fredrick; Hirschhorn, Joel N.; Kraft, Peter; Allen, Naomi E.; Albanes, Demetrius; Berglund, Goran; Berndt, Sonja I.; Boeing, Heiner; Bueno-de-Mesquita, H. Bas; Calle, Eugenia E.; Chanock, Stephen; Dunning, Alison M.; Hayes, Richard; Feigelson, Heather Spencer; Gaziano, J. Michael; Giovannucci, Edward; Haiman, Christopher A.; Henderson, Brian E.; Kaaks, Rudolf; Kolonel, Laurence N.; Jing, Ma; Rodriguez, Laudina; Riboli, Elio; Stampfer, Meir; Stram, Daniel O.; Thun, Michael J.; Tjønneland, Anne; Trichopoulos, Dimitrios; Vineis, Paolo; Virtamo, Jarmo; Le Marchand, Loïc; Hunter, David J.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 10, 10.2009, p. 2734-2744.

Research output: Contribution to journalArticle

Travis, RC, Schumacher, F, Hirschhorn, JN, Kraft, P, Allen, NE, Albanes, D, Berglund, G, Berndt, SI, Boeing, H, Bueno-de-Mesquita, HB, Calle, EE, Chanock, S, Dunning, AM, Hayes, R, Feigelson, HS, Gaziano, JM, Giovannucci, E, Haiman, CA, Henderson, BE, Kaaks, R, Kolonel, LN, Jing, M, Rodriguez, L, Riboli, E, Stampfer, M, Stram, DO, Thun, MJ, Tjønneland, A, Trichopoulos, D, Vineis, P, Virtamo, J, Le Marchand, L & Hunter, DJ 2009, 'CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium', Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 10, pp. 2734-2744. https://doi.org/10.1158/1055-9965.EPI-09-0496
Travis, Ruth C. ; Schumacher, Fredrick ; Hirschhorn, Joel N. ; Kraft, Peter ; Allen, Naomi E. ; Albanes, Demetrius ; Berglund, Goran ; Berndt, Sonja I. ; Boeing, Heiner ; Bueno-de-Mesquita, H. Bas ; Calle, Eugenia E. ; Chanock, Stephen ; Dunning, Alison M. ; Hayes, Richard ; Feigelson, Heather Spencer ; Gaziano, J. Michael ; Giovannucci, Edward ; Haiman, Christopher A. ; Henderson, Brian E. ; Kaaks, Rudolf ; Kolonel, Laurence N. ; Jing, Ma ; Rodriguez, Laudina ; Riboli, Elio ; Stampfer, Meir ; Stram, Daniel O. ; Thun, Michael J. ; Tjønneland, Anne ; Trichopoulos, Dimitrios ; Vineis, Paolo ; Virtamo, Jarmo ; Le Marchand, Loïc ; Hunter, David J. / CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 10. pp. 2734-2744.
@article{51bd916bec954a0da0c36505947594ff,
title = "CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium",
abstract = "Sex hormones, particularly the androgens, are important for the growth of the prostate gland and have been implicated in prostate cancer carcinogenesis, yet the determinants of endogenous steroid hormone levels remain poorly understood. Twin studies suggest a heritable component for circulating concentrations of sex hormones, although epidemiologic evidence linking steroid hormone gene variants to prostate cancer is limited. Here we report on findings from a comprehensive study of genetic variation at the CYP19A1 locus in relation to prostate cancer risk and to circulating steroid hormone concentrations in men by the Breast and Prostate Cancer Cohort Consortium (BPC3), a large collaborative prospective study. The BPC3 systematically characterized variation in CYP19A1 by targeted resequencing and dense genotyping; selected haplotypetagging single nucleotide polymorphisms (htSNP) that efficiently predict common variants in U.S. and European whites, Latinos, Japanese Americans, and Native Hawaiians; and genotyped these htSNPs in 8,166 prostate cancer cases and 9,079 study-, age-, and ethnicity-matched controls. CYP19A1 htSNPs, two common missense variants and common haplotypes were not significantly associated with risk of prostate cancer. However, several htSNPs in linkage disequilibrium blocks 3 and 4 were significantly associated with a 5{\%} to 10{\%} difference in estradiol concentrations in men [association per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 1 × 10-5], and with inverse, although less marked changes, in free testosterone concentrations. These results suggest that although germline variation in CYP19A1 characterized by the htSNPs produces measurable differences in sex hormone concentrations in men, they do not substantially influence risk of prostate cancer.",
author = "Travis, {Ruth C.} and Fredrick Schumacher and Hirschhorn, {Joel N.} and Peter Kraft and Allen, {Naomi E.} and Demetrius Albanes and Goran Berglund and Berndt, {Sonja I.} and Heiner Boeing and Bueno-de-Mesquita, {H. Bas} and Calle, {Eugenia E.} and Stephen Chanock and Dunning, {Alison M.} and Richard Hayes and Feigelson, {Heather Spencer} and Gaziano, {J. Michael} and Edward Giovannucci and Haiman, {Christopher A.} and Henderson, {Brian E.} and Rudolf Kaaks and Kolonel, {Laurence N.} and Ma Jing and Laudina Rodriguez and Elio Riboli and Meir Stampfer and Stram, {Daniel O.} and Thun, {Michael J.} and Anne Tj{\o}nneland and Dimitrios Trichopoulos and Paolo Vineis and Jarmo Virtamo and {Le Marchand}, Lo{\"i}c and Hunter, {David J.}",
year = "2009",
month = "10",
doi = "10.1158/1055-9965.EPI-09-0496",
language = "English (US)",
volume = "18",
pages = "2734--2744",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate cancer cohort consortium

AU - Travis, Ruth C.

AU - Schumacher, Fredrick

AU - Hirschhorn, Joel N.

AU - Kraft, Peter

AU - Allen, Naomi E.

AU - Albanes, Demetrius

AU - Berglund, Goran

AU - Berndt, Sonja I.

AU - Boeing, Heiner

AU - Bueno-de-Mesquita, H. Bas

AU - Calle, Eugenia E.

AU - Chanock, Stephen

AU - Dunning, Alison M.

AU - Hayes, Richard

AU - Feigelson, Heather Spencer

AU - Gaziano, J. Michael

AU - Giovannucci, Edward

AU - Haiman, Christopher A.

AU - Henderson, Brian E.

AU - Kaaks, Rudolf

AU - Kolonel, Laurence N.

AU - Jing, Ma

AU - Rodriguez, Laudina

AU - Riboli, Elio

AU - Stampfer, Meir

AU - Stram, Daniel O.

AU - Thun, Michael J.

AU - Tjønneland, Anne

AU - Trichopoulos, Dimitrios

AU - Vineis, Paolo

AU - Virtamo, Jarmo

AU - Le Marchand, Loïc

AU - Hunter, David J.

PY - 2009/10

Y1 - 2009/10

N2 - Sex hormones, particularly the androgens, are important for the growth of the prostate gland and have been implicated in prostate cancer carcinogenesis, yet the determinants of endogenous steroid hormone levels remain poorly understood. Twin studies suggest a heritable component for circulating concentrations of sex hormones, although epidemiologic evidence linking steroid hormone gene variants to prostate cancer is limited. Here we report on findings from a comprehensive study of genetic variation at the CYP19A1 locus in relation to prostate cancer risk and to circulating steroid hormone concentrations in men by the Breast and Prostate Cancer Cohort Consortium (BPC3), a large collaborative prospective study. The BPC3 systematically characterized variation in CYP19A1 by targeted resequencing and dense genotyping; selected haplotypetagging single nucleotide polymorphisms (htSNP) that efficiently predict common variants in U.S. and European whites, Latinos, Japanese Americans, and Native Hawaiians; and genotyped these htSNPs in 8,166 prostate cancer cases and 9,079 study-, age-, and ethnicity-matched controls. CYP19A1 htSNPs, two common missense variants and common haplotypes were not significantly associated with risk of prostate cancer. However, several htSNPs in linkage disequilibrium blocks 3 and 4 were significantly associated with a 5% to 10% difference in estradiol concentrations in men [association per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 1 × 10-5], and with inverse, although less marked changes, in free testosterone concentrations. These results suggest that although germline variation in CYP19A1 characterized by the htSNPs produces measurable differences in sex hormone concentrations in men, they do not substantially influence risk of prostate cancer.

AB - Sex hormones, particularly the androgens, are important for the growth of the prostate gland and have been implicated in prostate cancer carcinogenesis, yet the determinants of endogenous steroid hormone levels remain poorly understood. Twin studies suggest a heritable component for circulating concentrations of sex hormones, although epidemiologic evidence linking steroid hormone gene variants to prostate cancer is limited. Here we report on findings from a comprehensive study of genetic variation at the CYP19A1 locus in relation to prostate cancer risk and to circulating steroid hormone concentrations in men by the Breast and Prostate Cancer Cohort Consortium (BPC3), a large collaborative prospective study. The BPC3 systematically characterized variation in CYP19A1 by targeted resequencing and dense genotyping; selected haplotypetagging single nucleotide polymorphisms (htSNP) that efficiently predict common variants in U.S. and European whites, Latinos, Japanese Americans, and Native Hawaiians; and genotyped these htSNPs in 8,166 prostate cancer cases and 9,079 study-, age-, and ethnicity-matched controls. CYP19A1 htSNPs, two common missense variants and common haplotypes were not significantly associated with risk of prostate cancer. However, several htSNPs in linkage disequilibrium blocks 3 and 4 were significantly associated with a 5% to 10% difference in estradiol concentrations in men [association per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 1 × 10-5], and with inverse, although less marked changes, in free testosterone concentrations. These results suggest that although germline variation in CYP19A1 characterized by the htSNPs produces measurable differences in sex hormone concentrations in men, they do not substantially influence risk of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=70350114283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350114283&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0496

DO - 10.1158/1055-9965.EPI-09-0496

M3 - Article

C2 - 19789370

AN - SCOPUS:70350114283

VL - 18

SP - 2734

EP - 2744

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 10

ER -